Your browser doesn't support javascript.
loading
Risk/benefit of treating retroperitoneal teratoid bulky tumors.
Jaeger, N; Weissbach, L; Hartlapp, J H; Vahlensieck, W.
Afiliação
  • Jaeger N; University Urological Clinic, Bonn, F.R. Germany.
Urology ; 34(1): 14-7, 1989 Jul.
Article em En | MEDLINE | ID: mdl-2473568
Inductive polychemotherapy of germinal cell tumors in advanced stages (T0-4N3M0,1) is effective, yet accompanied by serious side effects. Partial remission necessitates resection of the residual tumor. The complications of the salvage operation are tolerable in proportion to its curativity. In a retrospective analysis, we evaluated the occurrence of toxic side effects and the frequency of intra- and postoperative complications in 128 patients with retroperitoneal teratoid bulky tumor. With a follow-up of three to one hundred ten months (means = 43 months), 91 patients (71%) are alive without evidence of disease; 28 patients (22%) died of apparent tumor progression.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retroperitoneais / Teratoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Urology Ano de publicação: 1989 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retroperitoneais / Teratoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Urology Ano de publicação: 1989 Tipo de documento: Article